Log In
BCIQ
Print this Print this
 

Androgen receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Androgen receptor

BCIQ
Print ChartPrint this
Marketed, 2 Marketed, 7 Marketed, 4 Approved, 1 Registration, 1 Phase III, 1 Phase III, 1 Phase III, 1 Phase III, 4 Phase II, 1 Phase II, 1 Phase II, 2 Phase II, 1 Phase II, 3 Phase I/II, 1 Phase I, 1 Phase I, 2 Phase I, 1 Phase I, 4 IND, 1 Preclinical, 1 Preclinical, 1 Preclinical, 1 Preclinical, 8
Phase of DevelopmentPreclinicalINDPhase IPhase I/IIPhase IIPhase IIIRegistrationApprovedMarketed
Cancer

8

1

4

1

3

4

-

-

4

Cardiovascular

-

-

1

-

-

-

-

-

-

Dermatology

-

-

-

-

1

-

-

-

-

Endocrine / Metabolic

1

-

2

-

2

1

1

1

7

Genitourinary

1

-

-

-

-

1

-

-

2

Musculoskeletal

1

-

1

-

1

1

-

-

-

Neurology

-

-

-

-

1

-

-

-

-




 Products Targeting Androgen receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

24

$164,757.5M

$162,149.0M

$2,645.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today